Mengna Li

2.0k total citations · 1 hit paper
82 papers, 1.4k citations indexed

About

Mengna Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mengna Li has authored 82 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 17 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Mengna Li's work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers) and Protein Degradation and Inhibitors (6 papers). Mengna Li is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers) and Protein Degradation and Inhibitors (6 papers). Mengna Li collaborates with scholars based in China, Saudi Arabia and Canada. Mengna Li's co-authors include Xinyan Li, Peiyue Li, Yuting Zhang, Guiyuan Li, Yumei Duan, Weihong Niu, Ming Zhou, Chunchun Wu, Yukun Liu and Wei Xiong and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Mengna Li

76 papers receiving 1.4k citations

Hit Papers

Appraising Groundwater Quality and Health Risks from Cont... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengna Li China 19 530 272 242 237 141 82 1.4k
Eung Seok Lee South Korea 25 539 1.0× 152 0.6× 152 0.6× 179 0.8× 153 1.1× 91 1.8k
Xuelian Liu China 21 578 1.1× 293 1.1× 81 0.3× 75 0.3× 99 0.7× 177 2.3k
Shuya Hu China 20 602 1.1× 289 1.1× 59 0.2× 85 0.4× 266 1.9× 44 1.2k
Jingru Zhang China 27 582 1.1× 308 1.1× 53 0.2× 133 0.6× 121 0.9× 142 2.4k
Haoming Chen China 21 291 0.5× 85 0.3× 88 0.4× 413 1.7× 109 0.8× 126 1.9k
Seok Soon Park South Korea 23 537 1.0× 116 0.4× 43 0.2× 473 2.0× 273 1.9× 59 1.8k
Honghan Chen China 24 320 0.6× 85 0.3× 117 0.5× 516 2.2× 59 0.4× 80 1.7k
Shuai Chen China 20 459 0.9× 302 1.1× 99 0.4× 48 0.2× 50 0.4× 85 1.3k
Jia Zhang China 21 423 0.8× 331 1.2× 43 0.2× 286 1.2× 81 0.6× 55 1.3k

Countries citing papers authored by Mengna Li

Since Specialization
Citations

This map shows the geographic impact of Mengna Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengna Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengna Li more than expected).

Fields of papers citing papers by Mengna Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengna Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengna Li. The network helps show where Mengna Li may publish in the future.

Co-authorship network of co-authors of Mengna Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mengna Li. A scholar is included among the top collaborators of Mengna Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengna Li. Mengna Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
4.
Li, Mengna, et al.. (2024). TFAP2A is involved in neuropathic pain by regulating Grin1 expression in glial cells of the dorsal root ganglion. Biochemical Pharmacology. 227. 116427–116427. 3 indexed citations
5.
Wang, Feiyang, Qianjin Liao, Jingyi Li, et al.. (2024). Autophagy: a critical mechanism of N6-methyladenosine modification involved in tumor progression and therapy resistance. Cell Death and Disease. 15(10). 783–783. 1 indexed citations
6.
Li, Mengna, Hao Chen, Minxiao Wang, et al.. (2024). Phenotypic plasticity of symbiotic organ highlight deep-sea mussel as model species in monitoring fluid extinction of deep-sea methane hydrate. The Science of The Total Environment. 958. 178048–178048. 2 indexed citations
7.
Li, Mengna, et al.. (2024). Discovery of PRMT3 Degrader for the Treatment of Acute Leukemia. Advanced Science. 11(38). e2405963–e2405963. 3 indexed citations
8.
Li, Mengna, Shipeng Chen, Yumei Duan, et al.. (2024). BRD7 enhances the radiosensitivity of nasopharyngeal carcinoma cells by negatively regulating USP5/METTL3 axis-mediated homologous recombination repair. International Journal of Biological Sciences. 20(15). 6130–6145. 4 indexed citations
9.
Li, Mengna, Shipeng Chen, Yumei Duan, et al.. (2023). CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene. Cancer Science. 115(1). 139–154. 6 indexed citations
10.
Li, Menghuan, Su Hu, Zhi Zuo, et al.. (2023). The role of the angiography-derived index of microcirculatory resistance in the prognosis of patients with dilated cardiomyopathy. Quantitative Imaging in Medicine and Surgery. 13(4). 2647–2659. 2 indexed citations
11.
Li, Mengna, Yukun Liu, Yumei Duan, et al.. (2023). BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma. Cell Death and Disease. 14(2). 121–121. 14 indexed citations
12.
Sun, Yan, Minxiao Wang, Lei Cao, et al.. (2023). Mosaic environment-driven evolution of the deep-sea mussel Gigantidas platifrons bacterial endosymbiont. Microbiome. 11(1). 253–253. 7 indexed citations
13.
14.
Zhang, Jie, Mengna Li, Yu Zhang, et al.. (2022). Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma. Frontiers in Oncology. 12. 818868–818868. 10 indexed citations
15.
Li, Mengna, Youmin Zhang, Jing Xin, et al.. (2021). Early Forest Fire Segmentation Based on Deep Learning. 1–5. 1 indexed citations
16.
Zhao, Ran, Yukun Liu, Chunchun Wu, et al.. (2021). BRD7 Promotes Cell Proliferation and Tumor Growth Through Stabilization of c-Myc in Colorectal Cancer. Frontiers in Cell and Developmental Biology. 9. 659392–659392. 19 indexed citations
17.
Chen, Rong, Yuxuan Zhao, Mengna Li, et al.. (2020). Efficient super‐resolution volumetric imaging by radial fluctuation Bayesian analysis light‐sheet microscopy. Journal of Biophotonics. 13(8). e201960242–e201960242. 9 indexed citations
18.
Wu, Chunchun, Mengna Li, Hanbing Meng, et al.. (2019). Analysis of status and countermeasures of cancer incidence and mortality in China. Science China Life Sciences. 62(5). 640–647. 222 indexed citations
19.
Li, Mengna, Yukun Liu, Chunchun Wu, et al.. (2019). Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc–mediated microRNA-141 transcription. Journal of Biological Chemistry. 294(15). 6172–6187. 28 indexed citations
20.
Liu, Yukun, Ran Zhao, Mengna Li, et al.. (2018). BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141. Journal of Experimental & Clinical Cancer Research. 37(1). 64–64. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026